MARK OLDAKOWSKI - 02 Feb 2026 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role: CHIEF OPERATING OFFICER
Signature: /s/ Jonathan V. Dixon, Attorney-in-Fact
Issuer symbol: BNGO
Transactions as of: 02 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 04 Feb 2026, 16:17:32 UTC
Previous filing: 12 Sep 2025
Next filing: 18 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
OLDAKOWSKI MARK	CHIEF OPERATING OFFICER	C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO	/s/ Jonathan V. Dixon, Attorney-in-Fact	04 Feb 2026	0001745566

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BNGO	Stock Option (Right to Buy)	Award	$0	+27,737		$0.000000	27,737	02 Feb 2026	Common Stock	27,737	$1.27	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date.